Carbidopa And Levodopa Tablet
Product Images NDC 0904-7549

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 0904-7549). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25mg/100mg Carton Label (3f6d393e Ac84 4a3c A837 199d1ec71fd2 00)

Carbidopa and Levodopa Tablets USP 25 mg/100 mg by Major Pharmaceuticals. The label shows a unit dose package containing 100 tablets (10 x 10). It includes dosage strength prominently in purple, NDC 0904-7501-61, and storage instructions. The label notes prescription use only and is manufactured in Australia by Major Pharmaceuticals, Indianapolis, IN.*

FDA Label Image

Chemical-structure (Carbilevo 01)

Chemical structure diagram of Carbidopa monohydrate, showing its hydroxylated benzene ring, amino acid side chain, and hydrating water molecule (H2O).*

FDA Label Image

Chemical-structure (Carbilevo 02)

Chemical structure of the active ingredient Levodopa, showing its molecular arrangement with hydroxyl groups and an amine group attached to the aromatic ring and side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.